查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1609020

更年期潮热市场：按治疗类型、分销管道划分 - 全球预测 2025-2030

Menopausal Hot Flashes Market by Treatment Type (Alternative Treatment, Hormonal Treatment, Non-Hormonal Treatment), Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 198 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年更年期潮热市场价值为82.4亿美元，预计到2024年将达到86.4亿美元，复合年增长率为6.18%，到2030年将达到125.4亿美元。

更年期潮热的特征是突然发热和出汗，主要影响更年期女性。市场研究范围包括评估潮热的盛行率、受影响最严重的人群、各种治疗方案（包括荷尔蒙疗法和非荷尔蒙疗法）的有效性以及患者的偏好。潮热引起的极大不适影响了生活质量，因此需要有效的解决方案。这项研究的应用范围从药物到自然疗法，最终用途延伸到医疗保健提供者和患者本身。市场开拓的主要驱动力包括女性意识的提高、治疗方案的进步以及製药公司对研发的大力投资。最近的机会在于数位健康解决方案和个人化医疗方法的整合，以满足患者的独特需求。为了利用这些机会，公司应专注于与高科技公司合作，透过数位平台提高患者的参与度和依从性。相反，监管障碍、荷尔蒙治疗相关副作用以及反对谈论更年期的文化偏见等挑战可能会阻碍市场扩张。克服这些问题需要有效的传播策略和监管应对措施。

主要市场统计
基准年[2023] 82.4亿美元
预计年份 [2024] 86.4亿美元
预测年份 [2030] 125.4亿美元
复合年增长率（%） 6.18%

新兴的创新领域包括非荷尔蒙疗法的开发，这些疗法吸引了那些寻求更安全替代品的人，例如选择性雌激素受体调节和草药补充品。此外，使用人工智慧来预测和管理症状指出了未来的成长途径。市场本身强劲而充满活力，在产品开发和服务提供方面具有巨大的创新空间，并呈现出积极的成长轨迹。专注于多通路行销策略、强大的售后支援和患者教育的公司将能够提高其市场占有率并与客户建立更深入的联繫。总体而言，利用技术和增加患者偏好对于永续成长非常重要。

市场动态：揭示快速发展的更年期潮热市场的关键市场洞察

供需的动态交互作用正在改变更年期潮热市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时也能帮助企业了解消费行为及其对製造业的影响。

  • 市场驱动因素
    • 月经热患病率上升
    • 提高消费者对更年期健康的认知
  • 市场限制因素
    • 与荷尔蒙製剂相关的副作用
  • 市场机会
    • 介绍先进技术的治疗方法
    • 与更年期过渡相关的新意识计划和宣传活动
  • 市场挑战
    • 学名药的存在

波特五力：驾驭更年期热潮市场的策略工具

波特的五力框架是了解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解外部对更年期潮热市场的影响

外部宏观环境因素对更年期潮热市场的表现动态起着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解更年期潮热市场的竞争状况

对更年期潮热市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵供应商在更年期潮热市场绩效评估

FPNV定位矩阵是评估更年期潮热市场供应商的关键工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，以确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议绘製更年期潮热市场的成功之路

对更年期潮热市场的策略分析对于旨在加强其在全球市场的影响力的公司至关重要。透过考虑关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 月经发烧的发生率增加
      • 提高消费者对更年期健康的认知
    • 抑制因素
      • 与荷尔蒙药物相关的副作用
    • 机会
      • 介绍先进技术的治疗方法
      • 更年期过渡意识计画和宣传活动的兴起
    • 任务
      • 学名药的存在
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章更年期潮热市场治疗类型

  • 替代治疗
    • 黑升麻
    • 草药
    • 维生素E
  • 荷尔蒙治疗
    • 雌激素
    • 雌激素和黄体素的组合
    • 黄体酮
  • 非荷尔蒙治疗

第七章更年期潮热市场：依通路分类

  • 医院药房
  • 网路药房
  • 零售药房

第八章 北美和南美更年期潮热市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第九章 亚太地区更年期潮热市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第10章欧洲、中东和非洲更年期潮热市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十一章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • A.Vogel Ltd.
  • Apotex Inc.
  • Astellas Pharma Inc.
  • Bayer AG
  • Fervent Pharmaceuticals, LLC
  • Glenmark Pharmaceuticals Ltd.
  • Mithra Pharmaceuticals
  • Novartis AG
  • Pfizer Inc.
  • Teva Pharmaceuticals Ltd.
  • TherapeuticsMD, Inc.
  • Zywie Ventures Private Limited
Product Code: MRR-742BD51814A1

The Menopausal Hot Flashes Market was valued at USD 8.24 billion in 2023, expected to reach USD 8.64 billion in 2024, and is projected to grow at a CAGR of 6.18%, to USD 12.54 billion by 2030.

Menopausal hot flashes are characterized by sudden warmth and sweating, primarily affecting women experiencing menopause. The scope of market research encompasses understanding the prevalence of hot flashes, the demographic segments most affected, and evaluating the efficacy and patient preference for various treatment options, including hormonal and non-hormonal therapies. The necessity for effective solutions stems from the significant discomfort hot flashes cause, impacting quality of life. Applications of this research are extensive, ranging from pharmaceuticals to natural remedies, with end-use extending towards healthcare providers and the patients themselves. Key market growth factors include increasing awareness among women, advancements in treatment options, and strong investment in research and development by pharmaceutical companies. Recent opportunities lie in the integration of digital health solutions and personalized medicine approaches that align with patient-specific needs. For businesses to capitalize on these opportunities, they should focus on partnerships with tech companies to enhance patient engagement and adherence through digital platforms. Conversely, challenges such as regulatory hurdles, side effects associated with hormonal treatments, and cultural stigmas about discussing menopause can impede market expansion. Overcoming these requires effective communication strategies and regulatory navigation.

KEY MARKET STATISTICS
Base Year [2023] USD 8.24 billion
Estimated Year [2024] USD 8.64 billion
Forecast Year [2030] USD 12.54 billion
CAGR (%) 6.18%

Emerging areas of innovation include the development of non-hormonal therapeutics, such as selective estrogen receptor modulators and herbal supplements, which appeal to those seeking safer alternatives. Additionally, the use of artificial intelligence to predict and manage symptoms presents a futuristic growth avenue. The market itself is robust yet dynamic, showing a positive growth trajectory with significant room for innovation in product development and service delivery. Companies focusing on multi-channel marketing strategies, robust after-market support, and patient education are likely to enhance their market presence and foster a more profound connection with their customers. Overall, leveraging technology and enhancing patient preference will be crucial for sustained growth.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Menopausal Hot Flashes Market

The Menopausal Hot Flashes Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising prevalence of menstrual fever
    • Increasing awareness of menopause health among consumers
  • Market Restraints
    • Associated side effects of hormonal products
  • Market Opportunities
    • Introduction of technologically advanced treatment
    • Emerging awareness programs and campaigns for menopausal transition
  • Market Challenges
    • Presence of generic medicines

Porter's Five Forces: A Strategic Tool for Navigating the Menopausal Hot Flashes Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Menopausal Hot Flashes Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Menopausal Hot Flashes Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Menopausal Hot Flashes Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Menopausal Hot Flashes Market

A detailed market share analysis in the Menopausal Hot Flashes Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Menopausal Hot Flashes Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Menopausal Hot Flashes Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Menopausal Hot Flashes Market

A strategic analysis of the Menopausal Hot Flashes Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Menopausal Hot Flashes Market, highlighting leading vendors and their innovative profiles. These include A.Vogel Ltd., Apotex Inc., Astellas Pharma Inc., Bayer AG, Fervent Pharmaceuticals, LLC, Glenmark Pharmaceuticals Ltd., Mithra Pharmaceuticals, Novartis AG, Pfizer Inc., Teva Pharmaceuticals Ltd., TherapeuticsMD, Inc., and Zywie Ventures Private Limited.

Market Segmentation & Coverage

This research report categorizes the Menopausal Hot Flashes Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Treatment Type, market is studied across Alternative Treatment, Hormonal Treatment, and Non-Hormonal Treatment. The Alternative Treatment is further studied across Black Cohosh, Herbal Medicines, and Vitamin E. The Hormonal Treatment is further studied across Estrogen, Estrogen-Progesterone Combination, and Progesterone.
  • Based on Distribution Channel, market is studied across Hospital Pharmacies, Online Pharmacies, and Retail Pharmacies.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising prevalence of menstrual fever
      • 5.1.1.2. Increasing awareness of menopause health among consumers
    • 5.1.2. Restraints
      • 5.1.2.1. Associated side effects of hormonal products
    • 5.1.3. Opportunities
      • 5.1.3.1. Introduction of technologically advanced treatment
      • 5.1.3.2. Emerging awareness programs and campaigns for menopausal transition
    • 5.1.4. Challenges
      • 5.1.4.1. Presence of generic medicines
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Menopausal Hot Flashes Market, by Treatment Type

  • 6.1. Introduction
  • 6.2. Alternative Treatment
    • 6.2.1. Black Cohosh
    • 6.2.2. Herbal Medicines
    • 6.2.3. Vitamin E
  • 6.3. Hormonal Treatment
    • 6.3.1. Estrogen
    • 6.3.2. Estrogen-Progesterone Combination
    • 6.3.3. Progesterone
  • 6.4. Non-Hormonal Treatment

7. Menopausal Hot Flashes Market, by Distribution Channel

  • 7.1. Introduction
  • 7.2. Hospital Pharmacies
  • 7.3. Online Pharmacies
  • 7.4. Retail Pharmacies

8. Americas Menopausal Hot Flashes Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Menopausal Hot Flashes Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Menopausal Hot Flashes Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. A.Vogel Ltd.
  • 2. Apotex Inc.
  • 3. Astellas Pharma Inc.
  • 4. Bayer AG
  • 5. Fervent Pharmaceuticals, LLC
  • 6. Glenmark Pharmaceuticals Ltd.
  • 7. Mithra Pharmaceuticals
  • 8. Novartis AG
  • 9. Pfizer Inc.
  • 10. Teva Pharmaceuticals Ltd.
  • 11. TherapeuticsMD, Inc.
  • 12. Zywie Ventures Private Limited

LIST OF FIGURES

  • FIGURE 1. MENOPAUSAL HOT FLASHES MARKET RESEARCH PROCESS
  • FIGURE 2. MENOPAUSAL HOT FLASHES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL MENOPAUSAL HOT FLASHES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL MENOPAUSAL HOT FLASHES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL MENOPAUSAL HOT FLASHES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL MENOPAUSAL HOT FLASHES MARKET SIZE, BY TREATMENT TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL MENOPAUSAL HOT FLASHES MARKET SIZE, BY TREATMENT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL MENOPAUSAL HOT FLASHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL MENOPAUSAL HOT FLASHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS MENOPAUSAL HOT FLASHES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS MENOPAUSAL HOT FLASHES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES MENOPAUSAL HOT FLASHES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES MENOPAUSAL HOT FLASHES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC MENOPAUSAL HOT FLASHES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC MENOPAUSAL HOT FLASHES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA MENOPAUSAL HOT FLASHES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA MENOPAUSAL HOT FLASHES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. MENOPAUSAL HOT FLASHES MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. MENOPAUSAL HOT FLASHES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. MENOPAUSAL HOT FLASHES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL MENOPAUSAL HOT FLASHES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL MENOPAUSAL HOT FLASHES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL MENOPAUSAL HOT FLASHES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. MENOPAUSAL HOT FLASHES MARKET DYNAMICS
  • TABLE 7. GLOBAL MENOPAUSAL HOT FLASHES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL MENOPAUSAL HOT FLASHES MARKET SIZE, BY ALTERNATIVE TREATMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL MENOPAUSAL HOT FLASHES MARKET SIZE, BY BLACK COHOSH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL MENOPAUSAL HOT FLASHES MARKET SIZE, BY HERBAL MEDICINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL MENOPAUSAL HOT FLASHES MARKET SIZE, BY VITAMIN E, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL MENOPAUSAL HOT FLASHES MARKET SIZE, BY ALTERNATIVE TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL MENOPAUSAL HOT FLASHES MARKET SIZE, BY HORMONAL TREATMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL MENOPAUSAL HOT FLASHES MARKET SIZE, BY ESTROGEN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL MENOPAUSAL HOT FLASHES MARKET SIZE, BY ESTROGEN-PROGESTERONE COMBINATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL MENOPAUSAL HOT FLASHES MARKET SIZE, BY PROGESTERONE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL MENOPAUSAL HOT FLASHES MARKET SIZE, BY HORMONAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL MENOPAUSAL HOT FLASHES MARKET SIZE, BY NON-HORMONAL TREATMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL MENOPAUSAL HOT FLASHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL MENOPAUSAL HOT FLASHES MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL MENOPAUSAL HOT FLASHES MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL MENOPAUSAL HOT FLASHES MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS MENOPAUSAL HOT FLASHES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS MENOPAUSAL HOT FLASHES MARKET SIZE, BY ALTERNATIVE TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS MENOPAUSAL HOT FLASHES MARKET SIZE, BY HORMONAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS MENOPAUSAL HOT FLASHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS MENOPAUSAL HOT FLASHES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA MENOPAUSAL HOT FLASHES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA MENOPAUSAL HOT FLASHES MARKET SIZE, BY ALTERNATIVE TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA MENOPAUSAL HOT FLASHES MARKET SIZE, BY HORMONAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA MENOPAUSAL HOT FLASHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL MENOPAUSAL HOT FLASHES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL MENOPAUSAL HOT FLASHES MARKET SIZE, BY ALTERNATIVE TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL MENOPAUSAL HOT FLASHES MARKET SIZE, BY HORMONAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 35. BRAZIL MENOPAUSAL HOT FLASHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 36. CANADA MENOPAUSAL HOT FLASHES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. CANADA MENOPAUSAL HOT FLASHES MARKET SIZE, BY ALTERNATIVE TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 38. CANADA MENOPAUSAL HOT FLASHES MARKET SIZE, BY HORMONAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 39. CANADA MENOPAUSAL HOT FLASHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 40. MEXICO MENOPAUSAL HOT FLASHES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. MEXICO MENOPAUSAL HOT FLASHES MARKET SIZE, BY ALTERNATIVE TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 42. MEXICO MENOPAUSAL HOT FLASHES MARKET SIZE, BY HORMONAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 43. MEXICO MENOPAUSAL HOT FLASHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 44. UNITED STATES MENOPAUSAL HOT FLASHES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. UNITED STATES MENOPAUSAL HOT FLASHES MARKET SIZE, BY ALTERNATIVE TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 46. UNITED STATES MENOPAUSAL HOT FLASHES MARKET SIZE, BY HORMONAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 47. UNITED STATES MENOPAUSAL HOT FLASHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 48. UNITED STATES MENOPAUSAL HOT FLASHES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 49. ASIA-PACIFIC MENOPAUSAL HOT FLASHES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. ASIA-PACIFIC MENOPAUSAL HOT FLASHES MARKET SIZE, BY ALTERNATIVE TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC MENOPAUSAL HOT FLASHES MARKET SIZE, BY HORMONAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 52. ASIA-PACIFIC MENOPAUSAL HOT FLASHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 53. ASIA-PACIFIC MENOPAUSAL HOT FLASHES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 54. AUSTRALIA MENOPAUSAL HOT FLASHES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. AUSTRALIA MENOPAUSAL HOT FLASHES MARKET SIZE, BY ALTERNATIVE TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 56. AUSTRALIA MENOPAUSAL HOT FLASHES MARKET SIZE, BY HORMONAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 57. AUSTRALIA MENOPAUSAL HOT FLASHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 58. CHINA MENOPAUSAL HOT FLASHES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. CHINA MENOPAUSAL HOT FLASHES MARKET SIZE, BY ALTERNATIVE TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 60. CHINA MENOPAUSAL HOT FLASHES MARKET SIZE, BY HORMONAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 61. CHINA MENOPAUSAL HOT FLASHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 62. INDIA MENOPAUSAL HOT FLASHES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. INDIA MENOPAUSAL HOT FLASHES MARKET SIZE, BY ALTERNATIVE TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 64. INDIA MENOPAUSAL HOT FLASHES MARKET SIZE, BY HORMONAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 65. INDIA MENOPAUSAL HOT FLASHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 66. INDONESIA MENOPAUSAL HOT FLASHES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. INDONESIA MENOPAUSAL HOT FLASHES MARKET SIZE, BY ALTERNATIVE TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 68. INDONESIA MENOPAUSAL HOT FLASHES MARKET SIZE, BY HORMONAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 69. INDONESIA MENOPAUSAL HOT FLASHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 70. JAPAN MENOPAUSAL HOT FLASHES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. JAPAN MENOPAUSAL HOT FLASHES MARKET SIZE, BY ALTERNATIVE TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 72. JAPAN MENOPAUSAL HOT FLASHES MARKET SIZE, BY HORMONAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 73. JAPAN MENOPAUSAL HOT FLASHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 74. MALAYSIA MENOPAUSAL HOT FLASHES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. MALAYSIA MENOPAUSAL HOT FLASHES MARKET SIZE, BY ALTERNATIVE TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 76. MALAYSIA MENOPAUSAL HOT FLASHES MARKET SIZE, BY HORMONAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 77. MALAYSIA MENOPAUSAL HOT FLASHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 78. PHILIPPINES MENOPAUSAL HOT FLASHES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. PHILIPPINES MENOPAUSAL HOT FLASHES MARKET SIZE, BY ALTERNATIVE TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 80. PHILIPPINES MENOPAUSAL HOT FLASHES MARKET SIZE, BY HORMONAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 81. PHILIPPINES MENOPAUSAL HOT FLASHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 82. SINGAPORE MENOPAUSAL HOT FLASHES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. SINGAPORE MENOPAUSAL HOT FLASHES MARKET SIZE, BY ALTERNATIVE TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 84. SINGAPORE MENOPAUSAL HOT FLASHES MARKET SIZE, BY HORMONAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 85. SINGAPORE MENOPAUSAL HOT FLASHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH KOREA MENOPAUSAL HOT FLASHES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH KOREA MENOPAUSAL HOT FLASHES MARKET SIZE, BY ALTERNATIVE TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH KOREA MENOPAUSAL HOT FLASHES MARKET SIZE, BY HORMONAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 89. SOUTH KOREA MENOPAUSAL HOT FLASHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 90. TAIWAN MENOPAUSAL HOT FLASHES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. TAIWAN MENOPAUSAL HOT FLASHES MARKET SIZE, BY ALTERNATIVE TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 92. TAIWAN MENOPAUSAL HOT FLASHES MARKET SIZE, BY HORMONAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 93. TAIWAN MENOPAUSAL HOT FLASHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 94. THAILAND MENOPAUSAL HOT FLASHES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. THAILAND MENOPAUSAL HOT FLASHES MARKET SIZE, BY ALTERNATIVE TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 96. THAILAND MENOPAUSAL HOT FLASHES MARKET SIZE, BY HORMONAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 97. THAILAND MENOPAUSAL HOT FLASHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 98. VIETNAM MENOPAUSAL HOT FLASHES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. VIETNAM MENOPAUSAL HOT FLASHES MARKET SIZE, BY ALTERNATIVE TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 100. VIETNAM MENOPAUSAL HOT FLASHES MARKET SIZE, BY HORMONAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 101. VIETNAM MENOPAUSAL HOT FLASHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA MENOPAUSAL HOT FLASHES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA MENOPAUSAL HOT FLASHES MARKET SIZE, BY ALTERNATIVE TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA MENOPAUSAL HOT FLASHES MARKET SIZE, BY HORMONAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA MENOPAUSAL HOT FLASHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA MENOPAUSAL HOT FLASHES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 107. DENMARK MENOPAUSAL HOT FLASHES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. DENMARK MENOPAUSAL HOT FLASHES MARKET SIZE, BY ALTERNATIVE TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 109. DENMARK MENOPAUSAL HOT FLASHES MARKET SIZE, BY HORMONAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 110. DENMARK MENOPAUSAL HOT FLASHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 111. EGYPT MENOPAUSAL HOT FLASHES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. EGYPT MENOPAUSAL HOT FLASHES MARKET SIZE, BY ALTERNATIVE TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 113. EGYPT MENOPAUSAL HOT FLASHES MARKET SIZE, BY HORMONAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 114. EGYPT MENOPAUSAL HOT FLASHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 115. FINLAND MENOPAUSAL HOT FLASHES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. FINLAND MENOPAUSAL HOT FLASHES MARKET SIZE, BY ALTERNATIVE TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 117. FINLAND MENOPAUSAL HOT FLASHES MARKET SIZE, BY HORMONAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 118. FINLAND MENOPAUSAL HOT FLASHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 119. FRANCE MENOPAUSAL HOT FLASHES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. FRANCE MENOPAUSAL HOT FLASHES MARKET SIZE, BY ALTERNATIVE TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 121. FRANCE MENOPAUSAL HOT FLASHES MARKET SIZE, BY HORMONAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 122. FRANCE MENOPAUSAL HOT FLASHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 123. GERMANY MENOPAUSAL HOT FLASHES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. GERMANY MENOPAUSAL HOT FLASHES MARKET SIZE, BY ALTERNATIVE TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 125. GERMANY MENOPAUSAL HOT FLASHES MARKET SIZE, BY HORMONAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 126. GERMANY MENOPAUSAL HOT FLASHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 127. ISRAEL MENOPAUSAL HOT FLASHES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. ISRAEL MENOPAUSAL HOT FLASHES MARKET SIZE, BY ALTERNATIVE TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 129. ISRAEL MENOPAUSAL HOT FLASHES MARKET SIZE, BY HORMONAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 130. ISRAEL MENOPAUSAL HOT FLASHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 131. ITALY MENOPAUSAL HOT FLASHES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. ITALY MENOPAUSAL HOT FLASHES MARKET SIZE, BY ALTERNATIVE TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 133. ITALY MENOPAUSAL HOT FLASHES MARKET SIZE, BY HORMONAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 134. ITALY MENOPAUSAL HOT FLASHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 135. NETHERLANDS MENOPAUSAL HOT FLASHES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. NETHERLANDS MENOPAUSAL HOT FLASHES MARKET SIZE, BY ALTERNATIVE TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 137. NETHERLANDS MENOPAUSAL HOT FLASHES MARKET SIZE, BY HORMONAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 138. NETHERLANDS MENOPAUSAL HOT FLASHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 139. NIGERIA MENOPAUSAL HOT FLASHES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. NIGERIA MENOPAUSAL HOT FLASHES MARKET SIZE, BY ALTERNATIVE TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 141. NIGERIA MENOPAUSAL HOT FLASHES MARKET SIZE, BY HORMONAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 142. NIGERIA MENOPAUSAL HOT FLASHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 143. NORWAY MENOPAUSAL HOT FLASHES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. NORWAY MENOPAUSAL HOT FLASHES MARKET SIZE, BY ALTERNATIVE TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 145. NORWAY MENOPAUSAL HOT FLASHES MARKET SIZE, BY HORMONAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 146. NORWAY MENOPAUSAL HOT FLASHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 147. POLAND MENOPAUSAL HOT FLASHES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 148. POLAND MENOPAUSAL HOT FLASHES MARKET SIZE, BY ALTERNATIVE TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 149. POLAND MENOPAUSAL HOT FLASHES MARKET SIZE, BY HORMONAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 150. POLAND MENOPAUSAL HOT FLASHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 151. QATAR MENOPAUSAL HOT FLASHES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 152. QATAR MENOPAUSAL HOT FLASHES MARKET SIZE, BY ALTERNATIVE TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 153. QATAR MENOPAUSAL HOT FLASHES MARKET SIZE, BY HORMONAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 154. QATAR MENOPAUSAL HOT FLASHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 155. RUSSIA MENOPAUSAL HOT FLASHES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 156. RUSSIA MENOPAUSAL HOT FLASHES MARKET SIZE, BY ALTERNATIVE TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 157. RUSSIA MENOPAUSAL HOT FLASHES MARKET SIZE, BY HORMONAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 158. RUSSIA MENOPAUSAL HOT FLASHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 159. SAUDI ARABIA MENOPAUSAL HOT FLASHES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 160. SAUDI ARABIA MENOPAUSAL HOT FLASHES MARKET SIZE, BY ALTERNATIVE TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 161. SAUDI ARABIA MENOPAUSAL HOT FLASHES MARKET SIZE, BY HORMONAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 162. SAUDI ARABIA MENOPAUSAL HOT FLASHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 163. SOUTH AFRICA MENOPAUSAL HOT FLASHES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 164. SOUTH AFRICA MENOPAUSAL HOT FLASHES MARKET SIZE, BY ALTERNATIVE TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 165. SOUTH AFRICA MENOPAUSAL HOT FLASHES MARKET SIZE, BY HORMONAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 166. SOUTH AFRICA MENOPAUSAL HOT FLASHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 167. SPAIN MENOPAUSAL HOT FLASHES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 168. SPAIN MENOPAUSAL HOT FLASHES MARKET SIZE, BY ALTERNATIVE TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 169. SPAIN MENOPAUSAL HOT FLASHES MARKET SIZE, BY HORMONAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 170. SPAIN MENOPAUSAL HOT FLASHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 171. SWEDEN MENOPAUSAL HOT FLASHES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 172. SWEDEN MENOPAUSAL HOT FLASHES MARKET SIZE, BY ALTERNATIVE TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 173. SWEDEN MENOPAUSAL HOT FLASHES MARKET SIZE, BY HORMONAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 174. SWEDEN MENOPAUSAL HOT FLASHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 175. SWITZERLAND MENOPAUSAL HOT FLASHES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 176. SWITZERLAND MENOPAUSAL HOT FLASHES MARKET SIZE, BY ALTERNATIVE TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 177. SWITZERLAND MENOPAUSAL HOT FLASHES MARKET SIZE, BY HORMONAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 178. SWITZERLAND MENOPAUSAL HOT FLASHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 179. TURKEY MENOPAUSAL HOT FLASHES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 180. TURKEY MENOPAUSAL HOT FLASHES MARKET SIZE, BY ALTERNATIVE TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 181. TURKEY MENOPAUSAL HOT FLASHES MARKET SIZE, BY HORMONAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 182. TURKEY MENOPAUSAL HOT FLASHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 183. UNITED ARAB EMIRATES MENOPAUSAL HOT FLASHES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED ARAB EMIRATES MENOPAUSAL HOT FLASHES MARKET SIZE, BY ALTERNATIVE TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED ARAB EMIRATES MENOPAUSAL HOT FLASHES MARKET SIZE, BY HORMONAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED ARAB EMIRATES MENOPAUSAL HOT FLASHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED KINGDOM MENOPAUSAL HOT FLASHES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED KINGDOM MENOPAUSAL HOT FLASHES MARKET SIZE, BY ALTERNATIVE TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED KINGDOM MENOPAUSAL HOT FLASHES MARKET SIZE, BY HORMONAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 190. UNITED KINGDOM MENOPAUSAL HOT FLASHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 191. MENOPAUSAL HOT FLASHES MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 192. MENOPAUSAL HOT FLASHES MARKET, FPNV POSITIONING MATRIX, 2023